LEADING CANCER RESEARCH
The new institute is a leader in important cancer research. At Texas Oncology–Tyler, a
trial and research program has helped in the development of major cancer breakthroughs like
immunotherapy drugs such as Opdivo and Keytruda. Tyler oncologists have offered more than
trials in which more than 8,100 area patients have participated.